Materias dentro de su búsqueda.
Mostrando 2,801 - 2,820 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 1.95s Limitar resultados
  1. 2801
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    UHMK1 Is a Novel Marker for Personalized Prediction of Pancreatic Cancer Prognosis
  2. 2802
    “…Pancreatic cancer is a highly aggressive malignancy that features high recurrence rates and the poorest prognosis of all solid cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
  3. 2803
    “…Over the past several decades in the United States, incidence of pancreatic cancer (PCa) has increased, with the 5-year survival rate remaining extremely low at 10.8%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A Pilot Study of Blood-Based Methylation Markers Associated With Pancreatic Cancer
  4. 2804
    “…Here, we explore the clinical significance of CTCs and T lymphocyte subtypes in patients with pancreatic cancer. A total of 106 patients with the pancreatic cancer were enrolled in this study. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients
  5. 2805
    “…BACKGROUND: Pancreatic cancer is one of the most prothrombotic cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
  6. 2806
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
  7. 2807
    “…Pancreatic cancer (PCa) is a highly lethal and aggressive disease, characterized by high mortality rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer
  8. 2808
    “…Pancreatic cancer is a malignancy of rising prevalence, especially in developed countries where dietary patterns and sedentariness favor its onset. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer
  9. 2809
    “…Pancreatic cancer is the fourth leading cause of cancer death, with a 5-year survival rate of 10%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism
  10. 2810
    “…BACKGROUND: The prognosis of pancreatic cancer is poor, with a 5-year survival rate of less than 10%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
  11. 2811
    “…However, the role of the KDM5 family in pancreatic cancer is not clear, and related research is very scarce. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Expression, Prognostic Value, and Functional Mechanism of the KDM5 Family in Pancreatic Cancer
  12. 2812
    “…Pancreatic cancer is a highly challenging malignancy with extremely poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cytoglobin attenuates pancreatic cancer growth via scavenging reactive oxygen species
  13. 2813
    “…Afterward, gemcitabine loaded Fe(3)O(4)@PMO (Fe(3)O(4)@PMO-Gem) is sequentially delivered to treat pancreatic cancer, which shows strong killing ability for the pancreatic cancer cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Sequential therapy for pancreatic cancer by losartan- and gemcitabine-loaded magnetic mesoporous spheres
  14. 2814
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model
  15. 2815
    “…CONCLUSION: NAM/GEM/S-1 therapy is safe and could be promising option for unresectable pancreatic cancer, especially for stage IV cancer.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
  16. 2816
    “…SIMPLE SUMMARY: Pancreatic cancer tissue is resistant to anticancer drugs because of its complex microenvironment. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating Cancer-Associated Fibroblasts
  17. 2817
    “…This work is performed to probe the role of IPO7 in pancreatic cancer development and its potential downstream mechanisms. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    IPO7 promotes pancreatic cancer progression via regulating ERBB pathway
  18. 2818
    por Chen, Ru, Pan, Sheng
    Publicado 2022
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Increased neutrophil infiltration as a body-wide effect in pancreatic cancer development
  19. 2819
    “…Chemotherapy resistance and peculiar tumor microenvironment, which diminish or mitigate the effects of therapies, make pancreatic cancer one of the deadliest malignancies to manage and treat. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
  20. 2820
    “…Chemotherapy is standard of care in all stages of pancreatic cancer, yet survival, particularly in the advanced stages, often remains under one year. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
Herramientas de búsqueda: RSS